You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

Medtronic
Moodys
Baxter
McKinsey
AstraZeneca
Dow

Last Updated: August 11, 2020

DrugPatentWatch Database Preview

CLINICAL TRIALS PROFILE FOR DIFLUPREDNATE

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

All Clinical Trials for difluprednate

Trial ID Title Status Sponsor Phase Start Date Summary
NCT00405496 Study of Difluprednate Ophthalmic Emulsion in the Treatment of Uveitis Completed Sirion Therapeutics, Inc. Phase 2 2000-03-01 The purpose of this phase 2 study is to determine if difluprednate ophthalmic emulsion is effective in the treatment of uveitis.
NCT00406341 Study of Difluprednate Ophthalmic Emulsion in Postoperative Inflammation Completed Sirion Therapeutics, Inc. Phase 3 2004-04-01 The purpose of this phase 3 study is to determine if difluprednate ophthalmic emulsion is effective in the treatment of postoperative inflammation.
NCT00406497 Study of Difluprednate Ophthalmic Emulsion in the Treatment of Postoperative Inflammation Completed Sirion Therapeutics, Inc. Phase 2 2003-04-01 The purpose of this phase 2 study is to determine if difluprednate ophthalmic emulsion is effective in the treatment of postoperative inflammation.
NCT00406887 Study of Difluprednate Ophthalmic Emulsion in the Treatment of Uveitis Completed Sirion Therapeutics, Inc. Phase 3 2002-08-01 The purpose of this phase 3 confirmatory study is to determine if difluprednate ophthalmic emulsion is effective in the treatment of treatment of uveitis.
NCT00407056 Study of Difluprednate Ophthalmic Emulsion in the Treatment of Severe Uveitis Completed Sirion Therapeutics, Inc. Phase 3 2002-08-01 The purpose of this phase 3 open-labeled study is to determine if difluprednate ophthalmic emulsion is effective in the treatment of severe uveitis.
NCT00407225 Study of Difluprednate Ophthalmic Emulsion in the Treatment of Postoperative Inflammation Completed Sirion Therapeutics, Inc. Phase 2 1999-12-01 The purpose of this phase 2 study is to determine if difluprednate ophthalmic emulsion is effective in the treatment of postoperative inflammation.
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for difluprednate

Condition Name

Condition Name for difluprednate
Intervention Trials
Inflammation 8
Uveitis 3
Anterior Uveitis 2
Panuveitis 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Condition MeSH

Condition MeSH for difluprednate
Intervention Trials
Inflammation 10
Uveitis 7
Uveitis, Anterior 4
Iridocyclitis 4
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Locations for difluprednate

Trials by Country

Trials by Country for difluprednate
Location Trials
United States 13
Mexico 3
India 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Trials by US State

Trials by US State for difluprednate
Location Trials
Texas 3
California 2
Missouri 2
South Carolina 1
New York 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Progress for difluprednate

Clinical Trial Phase

Clinical Trial Phase for difluprednate
Clinical Trial Phase Trials
Phase 4 4
Phase 3 11
Phase 2 4
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Status

Clinical Trial Status for difluprednate
Clinical Trial Phase Trials
Completed 15
Not yet recruiting 3
Recruiting 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Sponsors for difluprednate

Sponsor Name

Sponsor Name for difluprednate
Sponsor Trials
Sirion Therapeutics, Inc. 12
Alcon Research 4
Edward J. Holland 1
[disabled in preview] 3
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Sponsor Type

Sponsor Type for difluprednate
Sponsor Trials
Industry 17
Other 8
NIH 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Colorcon
McKinsey
Johnson and Johnson
Dow
Express Scripts
Merck

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.